FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
FDA Greenlights Higher-Dose Wegovy 7.2 mg as Novo Nordisk Fights Back Against Zepbound Dominance The weight-loss drug wars just heated up. The U.S. Food and Drug Administration has approved Novo Nordisk’s higher-dose version of Wegovy — a 7.2-milligram injection — giving the blockbuster semaglutide shot a fresh edge against rival Eli Lilly’s Zepbound. Novo plans … Read more